Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-22T05:14:12.500Z Has data issue: false hasContentIssue false

Medications to Treat Diabetes

from Section 2 - Medication Adverse Effects

Published online by Cambridge University Press:  30 May 2019

By
Curtis L. Triplitt
Edited by
Alan B. Ettinger ,
Deborah M. Weisbrot  and
Casey E. Gallimore
Alan B. Ettinger
Affiliation:
Safe Passage Diagnostics, New York
Deborah M. Weisbrot
Affiliation:
State University of New York, Stony Brook
Casey E. Gallimore
Affiliation:
University of Wisconsin
Get access
Type
Chapter
Information
Synopsis of Neurology, Psychiatry and Related Systemic Disorders , pp. 719 - 721
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Serrano, JS, et al. May acarbose impair valproate bioavailability? Meth Find Exp Clin Pharmacol. 1996; 18(Suppl C): 98.Google Scholar
Lee, NJ, Norris, SL, Thakurta, S. Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus. Ann Fam Med. 2010; 8: 542–9.CrossRefGoogle ScholarPubMed
Mietlicki Baase, EG, Hayes, MR. Amylin activates distributed CNS nuclei to control energy balance. Physiol Behav. 2014; 136: 39–46.Google Scholar
Contrave (naltrexone HCl/buproprion HCl) package insert. Deerfield, IL/La Jolla, CA: Takeda Pharmaceuticals American, Inc./Orexigen Therapeutics, Inc.; 2014.Google Scholar
Wile, DJ, Toth, C. Association of metformin, elevated homocysteine, and emthylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabet Care. 2010; 33: 156–61.Google Scholar
Lehrke, M, Marx, N, Patel, S, et al. Safety and tolerability of linagliptin in patients with type 2 diabetes: a comprehensive pooled analysis of 22 placebo-controlled studies. Clin Ther. 2014; 36: 1130–46.Google Scholar
Richard, KR, Shelburne, JS, Kirk, JK. Tolerability of dipeptidyl peptidase-4 inhibitors: a review. Clin Ther. 2011; 33: 1609–29.CrossRefGoogle ScholarPubMed
Willams-Herman, D, Engel, SS, Round, E, et al. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord. 2010; 10: 7.Google Scholar
Smits, MM, van Raalte, DH, Tonneijck, L, et al. GLP-1 based therapies: clinical implications for gastroenterologists. Gut. 2016; 65: 702–11.Google Scholar
Trujillo, JM, Nuffer, W, Ellis, SL. GLP-1 receptor agonists: a review of head-to-head clinical trials. Adv Endocrinol Metab. 2015; 6: 19–28.CrossRefGoogle Scholar
Van Bloemendall, L, IJzerman, RG, Ten Kulve, JS, et al. GLP-1 receptor activation modulates appetite and reward-related brain areas in humans. Diabetes. 2014; 63: 4186–96.Google Scholar
Waser, B, Blank, A, Karamitopoulou, E, Perren, A, Reubi, JI. Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas. Mod Pathol. 2015; 28: 391–402.Google Scholar
Invokana package insert. Titusville, NJ: Janssen Pharmaceuticals, 2013.Google Scholar
Contrave® package insert. Deerfield, IL/La Jolla, CA: Takeda Pharmaceuticals American, Inc./Orexigen Therapeutics, Inc.; 2014.Google Scholar
Niemi, M, Backman, JT, Neuvonen, M, et al. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide. Diabetologia. 2003; 46: 347–51.CrossRefGoogle ScholarPubMed
Xu, H, Williams, KM, Liauw, WS, et al. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol. 2008; 153: 1579–86.CrossRefGoogle ScholarPubMed
Horita, S, Makamura, M, Satoh, N et al. Thiazolidinediones and edema: recent advances in the pathogenesis of thiazolidinediones-induced renal sodium retention. PPAR Res. 2015; 2015: Article ID 646423.Google Scholar
Triplitt, C, Cersosimo, E, DeFronzo, R. Pioglitazone and alogliptin combination therapy in type 2 diabetes. A pathophysiologically sound treatment. Vasc Health Risk Manag. 2010; 6: 671–90.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×